Overview
- The Federal Trade Commission and the attorneys general of Alaska, Iowa, Nebraska and Texas filed a 123‑page complaint on Wednesday accusing the World Professional Association for Transgender Health of making false or unsubstantiated claims about puberty blockers, hormones and surgeries for minors.
- The suit says WPATH’s Standards of Care version 8 removed age limits, overstated evidence of benefit, understated harms, and was drafted to secure insurer payment so that clinicians who provide transition services would profit.
- Plaintiffs ask a federal judge in the Northern District of Texas to bar future violations of the FTC Act, impose civil penalties, and award relief to the participating states, using consumer‑protection tools to challenge a medical association rather than individual doctors.
- WPATH rejected the complaint and said it will defend on First Amendment and jurisdictional grounds, pointing to a May D.C. court ruling that temporarily blocked the agency’s probe after finding evidence of animus; that ruling is likely to be a central point in upcoming motions and appeals.
- The case highlights disputed science and testimony — including HHS reviews and detransitioner accounts cited by plaintiffs — and could affect clinicians, insurers and patients by changing how clinical guidance is evaluated, litigated and used to determine coverage.